Our researchers have collaborative projects with several biomedical and pharmaceutical companies, supported by PhD scholarships from NSW Health. If you are interested in working with us, please get in touch to find out more.
Learn more about the NSW Health PhD Partnership Program.
The ARC CFBD is a multidisciplinary collaboration of researchers from Monash University, the Drug Discovery Initiative, and Griffith University. The Centre provide state-of-the-art training for HDR students, with transformative research programs to build partnerships between university-based researchers and industry-based research end-users.
Learn more aboiut the ARC Centre for Fragment-based Design.
The DDI is proud to host the 2020 SPARK Sydney program in collaboration with the Faculty of Medicine and Health. SPARK is a translational research and education program that provides training, mentorship, and milestone funding to research teams working in early stage drug development.
Four teams, led by Dr Nicholas Hunt, Dr Pegah Veramini, Dr Michael Morris and Dr Shiyang Jia will participate this year. Over the next 12 months, the program will provide education, mentorship and funding necessary to advance their research discoveries. Teams will be matched with industry experts and personnel with experience that addresses knowledge gaps in the team. Participants will attend workshops and regular milestone meetings, with each team receiving $15,000 of seed funding to support their translational journey.
In partnership with MTPConnect, the DDI recently hosted the first Pre-IP forum, where an expert panel of industry representatives and venture capitalists gave feedback and guidance on DDI Members’ Pre-IP research projects across our five disease focus areas.
We are always looking to engage with anyone interested in early stage drug development. We run events throughout the year for researchers, medical professionals, industry representatives and the general public.
Find out more about past and upcoming events here.